Market Overview:
The global barbiturate drugs market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of sleep disorders and rising geriatric population. Additionally, the growing demand for combination drugs is also contributing to the growth of this market. However, stringent regulatory norms and side effects associated with barbiturate drugs are restraining the growth of this market. On the basis of type, ultra-short acting barbiturate segment is expected to register highest CAGR during forecast period due to its short duration action and easy availability in hospitals pharmacies across globe. On basis on application, hospital pharmacies segment is anticipated witness highest CAGR over forecast period owing rising number emergency surgeries being conducted globally coupled with increase in number outpatient visits for diagnosis purpose which directly boosts demand for barbiturates in hospitals setting across world .Regionally North America dominates global Barbiturate Drugs Market followed by Europe due high prevalence obstructive sleep apnea (OSA) & chronic insomnia cases in these regions respectively .
Product Definition:
A barbiturate is a drug that acts as a central nervous system depressant, and can therefore produce a wide range of effects, from mild sedation to death. Barbiturates are prescribed for the treatment of anxiety, insomnia, and seizures.
Ultra-Short Acting Barbiturate:
Ultra-Short acting barbiturate, also known as USBA or short-acting barbiturate is a type of Barbiturate drug. It's an intermediate acting form of the medication and has a duration of 3 to 4 hours. The medicine is used in the treatment for acute alcohol intoxication and severe chronic pain.
Short-Acting Barbiturate:
Short-acting barbiturates are a class of drug that binds to the brain receptor and produces effects such as drowsiness, dizziness, relaxation of muscles, decrease in heart rate and elevated blood pressure. The most commonly used short-acting barbiturate is pentobarbital (Nembutal), which is an FDA approved drug for treatment of insomnia.
Application Insights:
The hospital pharmacies segment dominated the market in 2017 and is expected to maintain its dominance over the forecast period. The growth of this segment can be attributed to factors such as an increase in surgeries, rise in prevalence of critical illnesses, and growing aging population. Hospital-based barbiturate drugs are preferred over other drugs due to their short half-life which allows them for a single dose administration. Furthermore, increasing number of hospitals coupled with rising healthcare spending is anticipated to boost industry growth during the study period.
The retail pharmacies accounted for 24% share of global revenue in 2017 owing to high penetration rates across developing countries where people still prefer purchasing medicines from local stores rather than online or via phone order services owing to various benefits associated with these channels such as personal attention from pharmacist regarding medication issues along with easy availability at convenient hours are expected fuel industry expansion during the forecast period.
Regional Analysis:
North America dominated the global barbiturate drugs market in 2017. The presence of well-established healthcare infrastructure, high awareness levels coupled with relatively higher disposable income and improved access to health care are some of the factors responsible for its large share. Moreover, increasing prevalence of sleep disorders coupled with rising adoption of sleeping pills by teenagers is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to be one of the fastest growing regions over the forecast period owing to improving economic status and growing population in countries such as India & China which have a high unmet clinical needs pertaining Barbiturates Drugs Market Professionalism (BDP).
The Middle East & Africa region is anticipated witness significant growth due its huge untapped opportunities along with constantly improving healthcare facilities.
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and respiratory disorders is expected to drive the demand for barbiturate drugs over the forecast period.
- Rising geriatric population is also anticipated to boost the market growth as this population is more susceptible to chronic diseases that require barbiturate drugs for treatment.
- Growing awareness about the benefits of barbiturate drugs in terms of reducing side effects associated with traditional treatments is projected to propel market growth during the forecast period.
- Technological advancements in drug delivery systems are likely to provide lucrative opportunities for market players over the next few years. This would help improve patient compliance and increase uptake of these drugs across various regions worldwide. 5) The increasing number of mergers and acquisitions among key players is expected to result in enhanced product offerings and competitive pricing strategies, which will further fuel market growth during the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Barbiturate Drugs Market Research Report
By Type
Ultra-Short Acting Barbiturate, Short-Acting Barbiturate, Long-Acting Barbiturate, Combination Drugs
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Pfizer, Merck, Eli Lilly, Mylan, Sanofi, Teva Pharmaceutical, Sumitomo Dainippon Pharma, Bausch Health, Oak Pharmaceuticals, Meda pharmaceuticals, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
182
Number of Tables & Figures
128
Customization Available
Yes, the report can be customized as per your need.
Global Barbiturate Drugs Market Report Segments:
The global Barbiturate Drugs market is segmented on the basis of:
Types
Ultra-Short Acting Barbiturate, Short-Acting Barbiturate, Long-Acting Barbiturate, Combination Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Merck
- Eli Lilly
- Mylan
- Sanofi
- Teva Pharmaceutical
- Sumitomo Dainippon Pharma
- Bausch Health
- Oak Pharmaceuticals
- Meda pharmaceuticals
- Pfizer
Highlights of The Barbiturate Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ultra-Short Acting Barbiturate
- Short-Acting Barbiturate
- Long-Acting Barbiturate
- Combination Drugs
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Barbiturate Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Barbiturate drugs are a type of medication that work by slowing down the activity of the brain. This can cause people to feel drowsy or sleepy.
Some of the major companies in the barbiturate drugs market are Pfizer, Merck, Eli Lilly, Mylan, Sanofi, Teva Pharmaceutical, Sumitomo Dainippon Pharma, Bausch Health, Oak Pharmaceuticals, Meda pharmaceuticals, Pfizer.
The barbiturate drugs market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Barbiturate Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Barbiturate Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Barbiturate Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Barbiturate Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Barbiturate Drugs Market Size & Forecast, 2020-2028
4.5.1 Barbiturate Drugs Market Size and Y-o-Y Growth
4.5.2 Barbiturate Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Ultra-Short Acting Barbiturate
5.2.2 Short-Acting Barbiturate
5.2.3 Long-Acting Barbiturate
5.2.4 Combination Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Barbiturate Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Barbiturate Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Ultra-Short Acting Barbiturate
9.6.2 Short-Acting Barbiturate
9.6.3 Long-Acting Barbiturate
9.6.4 Combination Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Ultra-Short Acting Barbiturate
10.6.2 Short-Acting Barbiturate
10.6.3 Long-Acting Barbiturate
10.6.4 Combination Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Ultra-Short Acting Barbiturate
11.6.2 Short-Acting Barbiturate
11.6.3 Long-Acting Barbiturate
11.6.4 Combination Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Ultra-Short Acting Barbiturate
12.6.2 Short-Acting Barbiturate
12.6.3 Long-Acting Barbiturate
12.6.4 Combination Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Ultra-Short Acting Barbiturate
13.6.2 Short-Acting Barbiturate
13.6.3 Long-Acting Barbiturate
13.6.4 Combination Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Barbiturate Drugs Market: Competitive Dashboard
14.2 Global Barbiturate Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Merck
14.3.3 Eli Lilly
14.3.4 Mylan
14.3.5 Sanofi
14.3.6 Teva Pharmaceutical
14.3.7 Sumitomo Dainippon Pharma
14.3.8 Bausch Health
14.3.9 Oak Pharmaceuticals
14.3.10 Meda pharmaceuticals
14.3.11 Pfizer
